{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:05:47Z","timestamp":1765782347970,"version":"3.48.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["25ek0109636s1103"],"award-info":[{"award-number":["25ek0109636s1103"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Japan Foundation for Pediatric Research, Ministry of Health, Labor and Welfare Research Program on Rare and Intractable Diseases Grant"},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Galactose, a monosaccharide, plays diverse biological roles in energy production, especially in the glycolysis and glycosylation of proteins and lipids. Galactose metabolism is mediated by the Leloir pathway, which comprises four key enzymes. Following lactose hydrolysis, galactose mutarotase (GALM) catalyzes the anomerization of \u03b2-D-galactose to \u03b1-D-galactose, providing a substrate for the downstream pathway. In 2019, GALM deficiency was defined as the fourth type of galactosemia. Affected individuals may develop cataracts similar to those observed in individuals with galactokinase deficiency, disrupting the subsequent steps in the Leloir pathway. However, cataracts generally occur less frequently and tend to be milder in patients with GALM deficiency, likely because of the partial compensation provided by spontaneous galactose mutarotation in aqueous solutions. Because lactose, the primary dietary source of galactose, is the predominant carbohydrate consumed until weaning, the timely initiation of lactose restriction can prevent or even reverse cataract formation. To date, other complications or adverse events, including those in heterozygous carriers of\n                    <jats:italic>GALM<\/jats:italic>\n                    variants, have not been clearly demonstrated. This review aims to synthesize current knowledge and findings of GALM deficiency on molecular mechanisms, clinical presentation, diagnostic approaches, carrier risk, and dietary management, with particular emphasis on cataract prevention and reversibility through early lactose restriction. By consolidating available evidence, we propose future research directions, with broader implications for newborn screening programs, clinical decision-making, and a deeper understanding of galactose metabolism.\n                  <\/jats:p>","DOI":"10.1038\/s10038-025-01439-6","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:13:27Z","timestamp":1765779207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Galactose mutarotase deficiency as the galactosemia type IV"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2188-5608","authenticated-orcid":false,"given":"Yoichi","family":"Wada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2052-9369","authenticated-orcid":false,"given":"Yu","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Mikami-Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3328-9571","authenticated-orcid":false,"given":"Osamu","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1002-8739","authenticated-orcid":false,"given":"Atsuo","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Kure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"1439_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2021.129898","volume":"1865","author":"F Conte","year":"2021","unstructured":"Conte F, Buuringen N, van, Voermans NC, Lefeber DJ. Galactose in human metabolism, glycosylation and congenital metabolic diseases: time for a closer look. Biochim Biophys Acta BBA Gen Subj. 2021;1865:129898.","journal-title":"Biochim Biophys Acta BBA Gen Subj"},{"key":"1439_CR2","doi-asserted-by":"publisher","first-page":"278S","DOI":"10.1093\/advances\/nmy022","volume":"9","author":"DK Dror","year":"2018","unstructured":"Dror DK, Allen LH. Overview of nutrients in human milk. Adv Nutr. 2018;9:278S\u2013294S.","journal-title":"Adv Nutr"},{"key":"1439_CR3","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41372-024-02029-8","volume":"44","author":"MB Belfort","year":"2024","unstructured":"Belfort MB, Stellwagen L, North K, Unger S, O\u2019Connor DL, Perrin MT. Deciphering macronutrient information about human milk. J Perinatol. 2024;44:1377\u201381.","journal-title":"J Perinatol"},{"key":"1439_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3168\/jds.2024-25393","volume":"108","author":"IC Antunes","year":"2025","unstructured":"Antunes IC, Roseiro C, Bexiga R, Pinto C, Lageiro M, Gon\u00e7alves H, et al. Carbohydrate composition of cow milk and plant-based milk alternatives. J Dairy Sci. 2025;108:164\u201372.","journal-title":"J Dairy Sci"},{"key":"1439_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ajcn\/nqz104","volume":"110","author":"RA Forsg\u00e5rd","year":"2019","unstructured":"Forsg\u00e5rd RA. Lactose digestion in humans: intestinal lactase appears to be constitutive whereas the colonic microbiome is adaptable. Am J Clin Nutr. 2019;110:273\u20139.","journal-title":"Am J Clin Nutr"},{"key":"1439_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.nutres.2021.02.003","volume":"89","author":"R Catanzaro","year":"2021","unstructured":"Catanzaro R, Sciuto M, Marotta F. Lactose intolerance: an update on its pathogenesis, diagnosis, and treatment. Nutr Res. 2021;89:23\u201334.","journal-title":"Nutr Res"},{"key":"1439_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/jimd.12202","volume":"43","author":"M Haskovic","year":"2020","unstructured":"Haskovic M, Coelho AI, Bierau J, Vanoevelen JM, Steinbusch LKM, Zimmermann LJI, et al. Pathophysiology and targets for treatment in hereditary galactosemia: a systematic review of animal and cellular models. J Inherit Metab Dis. 2020;43:392\u2013408.","journal-title":"J Inherit Metab Dis"},{"key":"1439_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ymgme.2022.07.005","volume":"137","author":"JL Fridovich-Keil","year":"2022","unstructured":"Fridovich-Keil JL, Berry GT. Pathophysiology of long-term complications in classic galactosemia: what we do and do not know. Mol Genet Metab. 2022;137:33\u201339.","journal-title":"Mol Genet Metab"},{"key":"1439_CR9","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41436-018-0340-x","volume":"21","author":"Y Wada","year":"2019","unstructured":"Wada Y, Kikuchi A, Arai-Ichinoi N, Sakamoto O, Takezawa Y, Iwasawa S, et al. Biallelic GALM pathogenic variants cause a novel type of galactosemia. Genet Med. 2019;21:1286\u201394.","journal-title":"Genet Med"},{"key":"1439_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/ijns7040068","volume":"7","author":"A Kikuchi","year":"2021","unstructured":"Kikuchi A, Wada Y, Ohura T, Kure S. The discovery of GALM deficiency (type IV galactosemia) and newborn screening system for galactosemia in Japan. Int J Neonatal Screen. 2021;7:68.","journal-title":"Int J Neonatal Screen"},{"key":"1439_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biochi.2020.11.001","volume":"183","author":"S Banford","year":"2020","unstructured":"Banford S, Timson DJ. The structural and molecular biology of type IV galactosemia. Biochimie. 2020;183:13\u201317.","journal-title":"Biochimie"},{"key":"1439_CR12","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/s12887-024-05074-6","volume":"24","author":"P S\u00e1nchez-Pintos","year":"2024","unstructured":"S\u00e1nchez-Pintos P, Camba-Garea MJ, L\u00f3pez-Pardo BM, de Juan JAC, B\u00f3veda MD, Barbosa-Gouveia S, et al. Clinical and biochemical evolution after partial dietary liberalization of two cases of galactosemia due to galactose mutarotase deficiency. BMC Pediatr. 2024;24:620.","journal-title":"BMC Pediatr"},{"key":"1439_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101165","volume":"26","author":"Y Mikami-Saito","year":"2024","unstructured":"Mikami-Saito Y, Wada Y, Arai-Ichinoi N, Nakajima Y, Suzuki-Ajihara S, Murayama K, et al. Phenotypic and genetic spectra of galactose mutarotase deficiency: a nationwide survey conducted in Japan. Genet Med. 2024;26:101165.","journal-title":"Genet Med"},{"key":"1439_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/ijns11020025","volume":"11","author":"Konijnenburg EMMH van","year":"2025","unstructured":"Konijnenburg EMMH van, Radenkovic S, Koop K, Prinsen HCMT, de S derVelden M. Rethinking newborn screening: a case of GALM deficiency. Int J Neonatal Screen. 2025;11:25.","journal-title":"Int J Neonatal Screen"},{"key":"1439_CR15","first-page":"799","volume":"58","author":"V Reuss","year":"1908","unstructured":"Reuss V. Zuckerausscheidung im S\u00e4uglingsalter. Wien Med Wochenschr. 1908;58:799\u2013803.","journal-title":"Wien Med Wochenschr"},{"key":"1439_CR16","first-page":"473","volume":"54","author":"F G\u00f6ppert","year":"1917","unstructured":"G\u00f6ppert F. Galaktosurie nach Milchzuckergabe bei angeborenem, familiaerem chronischem Leberleiden. Klin Wochenschr. 1917;54:473\u20137.","journal-title":"Klin Wochenschr"},{"key":"1439_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1126\/science.123.3198.635","volume":"123","author":"KJ Isselbacher","year":"1956","unstructured":"Isselbacher KJ, Anderson EP, Kurahashi K, Kalckar HM. Congenital galactosemia, a single enzymatic block in galactose metabolism. Science. 1956;123:635\u20136.","journal-title":"Science"},{"key":"1439_CR18","unstructured":"Berry GT. Classic galactosemia and clinical variant galactosemia. In: GeneReviews. Seattle: (University of Washington, 2021)."},{"key":"1439_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10545-017-0029-3","volume":"40","author":"AI Coelho","year":"2017","unstructured":"Coelho AI, Rubio-Gozalbo ME, Vicente JB, Rivera I. Sweet and sour: an update on classic galactosemia. J Inherit Metab Dis. 2017;40:325\u201342.","journal-title":"J Inherit Metab Dis"},{"key":"1439_CR20","doi-asserted-by":"publisher","unstructured":"Walter JH, Fridovich-Keil JL. Galactosemia. The online metabolic and molecular bases of inherited disease. https:\/\/doi.org\/10.1036\/ommbid.381 (2021).","DOI":"10.1036\/ommbid.381"},{"key":"1439_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ymgme.2012.03.007","volume":"106","author":"GT Berry","year":"2012","unstructured":"Berry GT. Galactosemia: when is it a newborn screening emergency?. Mol Genet Metab. 2012;106:7\u201311.","journal-title":"Mol Genet Metab"},{"key":"1439_CR22","first-page":"137","volume":"68","author":"E Beutler","year":"1966","unstructured":"Beutler E, Baluda MC. A simple spot screening test for galactosemia. J Lab Clin Med. 1966;68:137\u201341.","journal-title":"J Lab Clin Med"},{"key":"1439_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJM197104082841404","volume":"284","author":"VE Shih","year":"1971","unstructured":"Shih VE, Levy HL, Karolkewicz V, Houghton S, Efron ML, Isselbacher KJ, et al. Galactosemia screening of newborns in Massachusetts. N Engl J Med. 1971;284:753\u20137.","journal-title":"N Engl J Med"},{"key":"1439_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/ijns10020038","volume":"10","author":"BL Therrell","year":"2024","unstructured":"Therrell BL, Padilla CD, Borrajo GJC, Khneisser I, Schielen PCJI, Knight-Madden J, et al. Current status of newborn bloodspot screening worldwide 2024: a comprehensive review of recent activities (2020\u20132023). Int J Neonatal Screen. 2024;10:38.","journal-title":"Int J Neonatal Screen"},{"key":"1439_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1047-z","volume":"14","author":"ME Rubio-Gozalbo","year":"2019","unstructured":"Rubio-Gozalbo ME, Haskovic M, Bosch AM, Burnyte B, Coelho AI, Cassiman D, et al. The natural history of classic galactosemia: lessons from the GalNet registry. Orphanet J Rare Dis. 2019;14:86.","journal-title":"Orphanet J Rare Dis"},{"key":"1439_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2023.107708","volume":"140","author":"NH Smith","year":"2023","unstructured":"Smith NH, Hendrickson ET, Garrett OS, Chernoff RA, Orloff DH, Druss JJ, et al. Long-term complications in classic galactosemia are not progressive. Mol Genet Metab. 2023;140:107708.","journal-title":"Mol Genet Metab"},{"key":"1439_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12786","volume":"48","author":"OS Garrett","year":"2025","unstructured":"Garrett OS, Druss JJ, Vos EN, Fu YD, Lucia S, Greenstein PE, et al. Health and well-being of maturing adults with classic galactosemia. J Inherit Metab Dis. 2025;48:e12786.","journal-title":"J Inherit Metab Dis"},{"key":"1439_CR28","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/GIM.0b013e3181c0c38d","volume":"11","author":"KK Powell","year":"2009","unstructured":"Powell KK, Braun KVN, Singh RH, Shapira SK, Olney RS, Yeargin-Allsopp M. Long-term speech and language developmental issues among children with Duarte galactosemia. Genet Med. 2009;11:874\u20139.","journal-title":"Genet Med"},{"key":"1439_CR29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2516","volume":"143","author":"G Carlock","year":"2019","unstructured":"Carlock G, Fischer ST, Lynch ME, Potter NL, Coles CD, Epstein MP, et al. Developmental outcomes in Duarte galactosemia. Pediatrics. 2019;143:e20182516.","journal-title":"Pediatrics"},{"key":"1439_CR30","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1038\/s41436-019-0567-1","volume":"21","author":"JL Fridovich-Keil","year":"2019","unstructured":"Fridovich-Keil JL, Carlock G, Coles CD, Lynch ME, Millians MN, Potter NL, et al. Developmental outcomes of children with Duarte galactosemia: exploring the bases of an apparent contradiction in the literature. Genet Med. 2019;21:2683\u20135.","journal-title":"Genet Med"},{"key":"1439_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0021-9258(19)51153-X","volume":"184","author":"R Caputto","year":"1950","unstructured":"Caputto R, Leloir LF, Cardini CE, Paladini AC. Isolation of the coenzyme of the galactose phosphate-glucose phosphate transformation. J Biol Chem. 1950;184:333\u201350.","journal-title":"J Biol Chem"},{"key":"1439_CR32","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1073\/pnas.45.12.1776","volume":"45","author":"HM Kalckar","year":"1959","unstructured":"Kalckar HM, Kurahashi K, Jordan E. Hereditary defects in galactose metabolism in Escherichia coli mutants, I. Determination of enzyme activities. Proc Natl Acad Sci. 1959;45:1776\u201386.","journal-title":"Proc Natl Acad Sci"},{"key":"1439_CR33","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1126\/science.172.3990.1299","volume":"172","author":"LF Leloir","year":"1971","unstructured":"Leloir LF. Two decades of research on biosynthesis of Saccharides. Science. 1971;172:1299\u2013303.","journal-title":"Science"},{"key":"1439_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1096\/fasebj.10.4.8647345","volume":"10","author":"PA Frey","year":"1996","unstructured":"Frey PA. The Leloir pathway: A mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. FASEB J. 1996;10:461\u201370.","journal-title":"FASEB J"},{"key":"1439_CR35","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jama.1961.03040470079019","volume":"178","author":"R Guthrie","year":"1961","unstructured":"Guthrie R. Blood screening for phenylketonuria. JAMA. 1961;178:863\u2013863.","journal-title":"JAMA"},{"key":"1439_CR36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S0140-6736(65)90400-9","volume":"286","author":"R Gitzelmann","year":"1965","unstructured":"Gitzelmann R. Deficiency of erythrocyte galactokinase in a patient with galactose diabetes. Lancet. 1965;286:670\u20131.","journal-title":"Lancet"},{"key":"1439_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1023\/A:1022875629436","volume":"25","author":"AM Bosch","year":"2003","unstructured":"Bosch AM, Bakker HD, Gennip AH, Kempen JV, Wanders RJA, Wijburg FA. Clinical features of galactokinase deficiency: a review of the literature. J Inherit Metab Dis. 2003;25:629\u201334.","journal-title":"J Inherit Metab Dis"},{"key":"1439_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10545-010-9270-8","volume":"34","author":"JB Hennermann","year":"2011","unstructured":"Hennermann JB, Schadewaldt P, Vetter B, Shin YS, M\u00f6nch E, Klein J. Features and outcome of galactokinase deficiency in children diagnosed by newborn screening. J Inherit Metab Dis. 2011;34:399\u2013407.","journal-title":"J Inherit Metab Dis"},{"key":"1439_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41436-020-00942-9","volume":"23","author":"ME Rubio-Gozalbo","year":"2021","unstructured":"Rubio-Gozalbo ME, Derks B, Das AM, Meyer U, M\u00f6slinger D, Couce ML, et al. Galactokinase deficiency: lessons from the GalNet registry. Genet Med. 2021;23:202\u201310.","journal-title":"Genet Med"},{"key":"1439_CR40","first-page":"125","volume":"27","author":"R Gitzelmann","year":"1972","unstructured":"Gitzelmann R. Deficiency of uridine diphosphate galactose 4-epimerase in blood cells of an apparently healthy infant. Preliminary communication. Helv Paediatr Acta. 1972;27:125\u201330.","journal-title":"Helv Paediatr Acta"},{"key":"1439_CR41","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1086\/302263","volume":"64","author":"TM Wohlers","year":"1999","unstructured":"Wohlers TM, Christacos NC, Harreman MT, Fridovich-Keil JL. Identification and characterization of a mutation, in the human UDP-galactose-4-epimerase gene, associated with generalized epimerase-deficiency galactosemia. Am J Hum Genet. 1999;64:462\u201370.","journal-title":"Am J Hum Genet"},{"key":"1439_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02494-4","volume":"17","author":"B Derks","year":"2022","unstructured":"Derks B, Demirbas D, Arantes RR, Banford S, Burlina AB, Cabrera A, et al. Galactose epimerase deficiency: lessons from the GalNet registry. Orphanet J Rare Dis. 2022;17:331.","journal-title":"Orphanet J Rare Dis"},{"key":"1439_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1023\/A:1005342306080","volume":"21","author":"A Alano","year":"1998","unstructured":"Alano A, Almashanu S, Chinsky JM, Costeas P, Blitzer MG, Wulfsberg EA, et al. Molecular characterization of a unique patient with epimerase-deficiency galactosaemia. J Inherit Metab Dis. 1998;21:341\u201350.","journal-title":"J Inherit Metab Dis"},{"key":"1439_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1086\/498985","volume":"78","author":"KK Openo","year":"2006","unstructured":"Openo KK, Schulz JM, Vargas CA, Orton CS, Epstein MP, Schnur RE, et al. Epimerase-deficiency galactosemia is not a binary condition. Am J Hum Genet. 2006;78:89\u2013102.","journal-title":"Am J Hum Genet"},{"key":"1439_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/hmg\/ddy334","volume":"28","author":"A Seo","year":"2018","unstructured":"Seo A, Gulsuner S, Pierce S, Ben-Harosh M, Shalev H, Walsh T, et al. Inherited thrombocytopenia associated with mutation of UDP-galactose-4-epimerase (GALE). Hum Mol Genet. 2018;28:133\u201342.","journal-title":"Hum Mol Genet"},{"key":"1439_CR46","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1002\/ajmg.a.62384","volume":"185","author":"R Markovitz","year":"2021","unstructured":"Markovitz R, Owen N, Satter LF, Kirk S, Mahoney DH, Bertuch AA, et al. Expansion of the clinical phenotype of GALE deficiency. Am J Med Genet A. 2021;185:3118\u201321.","journal-title":"Am J Med Genet A"},{"key":"1439_CR47","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1182\/blood.2022016995","volume":"141","author":"A Mar\u00edn-Quilez","year":"2022","unstructured":"Mar\u00edn-Quilez A, Buduo CAD, D\u00edaz-Ajenjo L, Abbonante V, Vuelta E, Soprano PMM, et al. Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis. Blood. 2022;141:406\u201321.","journal-title":"Blood"},{"key":"1439_CR48","doi-asserted-by":"publisher","first-page":"43885","DOI":"10.1074\/jbc.R300025200","volume":"278","author":"HM Holden","year":"2003","unstructured":"Holden HM, Rayment I, Thoden JB. Structure and function of enzymes of the leloir pathway for galactose metabolism. J Biol Chem. 2003;278:43885\u20138.","journal-title":"J Biol Chem"},{"key":"1439_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0014-5793(03)00364-8","volume":"543","author":"DJ Timson","year":"2003","unstructured":"Timson DJ, Reece RJ. Identification and characterisation of human aldose 1-epimerase. FEBS Lett. 2003;543:21\u201324.","journal-title":"FEBS Lett"},{"key":"1439_CR50","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/150634a0","volume":"150","author":"CE Coulthard","year":"1942","unstructured":"Coulthard CE, Michaelis R, Short WF, Sykes G, Skrimshire GEH, Standfast AFB, et al. Notatin: An anti-bacterial glucose-aerodehydrogenase from Penicillium notatum Westling. Nature. 1942;150:634\u20135.","journal-title":"Nature"},{"key":"1439_CR51","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1042\/bj0500341","volume":"50","author":"D Keilin","year":"1952","unstructured":"Keilin D, Hartree EF. Biological catalysis of mutarotation of glucose. Biochem J. 1952;50:341\u20138.","journal-title":"Biochem J"},{"key":"1439_CR52","doi-asserted-by":"publisher","first-page":"23431","DOI":"10.1074\/jbc.M402347200","volume":"279","author":"JB Thoden","year":"2004","unstructured":"Thoden JB, Timson DJ, Reece RJ, Holden HM. Molecular Structure of Human Galactose Mutarotase. J Biol Chem. 2004;279:23431\u20137.","journal-title":"J Biol Chem"},{"key":"1439_CR53","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0022-2836(91)90212-O","volume":"222","author":"S Cayley","year":"1991","unstructured":"Cayley S, Lewis BA, Guttman HJ, Record MT. Characterization of the cytoplasm of Escherichia coli K-12 as a function of external osmolarity Implications for protein-DNA interactions in vivo. J Mol Biol. 1991;222:281\u2013300.","journal-title":"J Mol Biol"},{"key":"1439_CR54","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1006\/jmbi.1994.1728","volume":"244","author":"GG Bouffard","year":"1994","unstructured":"Bouffard GG, Rudd KE, Adhya SL. Dependence of lactose metabolism upon mutarotase encoded in the gal operon in Escherichia coli. J Mol Biol. 1994;244:269\u201378.","journal-title":"J Mol Biol"},{"key":"1439_CR55","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1567-1364.2009.00517.x","volume":"9","author":"T Fukasawa","year":"2009","unstructured":"Fukasawa T, Sakurai H, Nogi Y, Baruffini E. Galactose transporters discriminate steric anomers at the cell surface in yeast. FEMS Yeast Res. 2009;9:723\u201331.","journal-title":"FEMS Yeast Res"},{"key":"1439_CR56","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1651-2227.1998.tb01521.x","volume":"87","author":"H Ono","year":"1998","unstructured":"Ono H, Mawatari H, Mizoguchi N, Eguchi T, Sakura N. Clinical features and outcome of eight infants with intrahepatic porto-venous shunts detected in neonatal screening for galactosaemia. Acta Paediatr. 1998;87:631\u20134.","journal-title":"Acta Paediatr"},{"key":"1439_CR57","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1442-200X.1988.tb02533.x","volume":"30","author":"K Aoki","year":"1988","unstructured":"Aoki K, Wada Y. Outcome of the patients detected by newborn screening in Japan. Pediatr Int. 1988;30:429\u201334.","journal-title":"Pediatr Int"},{"key":"1439_CR58","first-page":"68","volume":"48","author":"M Owada","year":"2012","unstructured":"Owada M, Aoki K. Newborn screening for inborn errors of galactose metabolism: verification of the incidence of galactosemia types I, II, and III. Tokushu Milk Joho. 2012;48:68\u201373.","journal-title":"Tokushu Milk Joho"},{"key":"1439_CR59","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41436-018-0359-z","volume":"21","author":"DJ Timson","year":"2018","unstructured":"Timson DJ. Type IV galactosemia. Genet Med. 2018;21:1283\u20135.","journal-title":"Genet Med"},{"key":"1439_CR60","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ymgme.2019.01.018","volume":"126","author":"S Iwasawa","year":"2019","unstructured":"Iwasawa S, Kikuchi A, Wada Y, Arai-Ichinoi N, Sakamoto O, Tamiya G, et al. The prevalence of GALM mutations that cause galactosemia: a database of functionally evaluated variants. Mol Genet Metab. 2019;126:362\u20137.","journal-title":"Mol Genet Metab"},{"key":"1439_CR61","first-page":"25","volume":"63","author":"H Yazici","year":"2022","unstructured":"Yazici H, Canda E, Alt\u0131nok YA, Ucar SK, Coker M. Two siblings with galactose mutarotase deficiency: clinical differences. JIMD Rep. 2022;63:25\u201328.","journal-title":"JIMD Rep"},{"key":"1439_CR62","first-page":"101048","volume":"38","author":"H-A Chen","year":"2024","unstructured":"Chen H-A, Hsu R-H, Chen L-C, Lee N-C, Chiu P-C, Hwu W-L, et al. Twelve-year review of galactosemia newborn screening in Taiwan: evolving methods and insights. Mol Genet Metab Rep. 2024;38:101048.","journal-title":"Mol Genet Metab Rep"},{"key":"1439_CR63","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/adc.31.158.254","volume":"31","author":"GM Komrower","year":"1956","unstructured":"Komrower GM, Schwarz V, Holzel A, Golberg L. A Clinical and biochemical study of galactosaemia. Arch Dis Child. 1956;31:254.","journal-title":"Arch Dis Child"},{"key":"1439_CR64","first-page":"115","volume":"66","author":"WG Ng","year":"1965","unstructured":"Ng WG, Donnell GN, Bergren WR. Galactokinase activity in human erythrocytes of individuals at different ages. J Lab Clin Med. 1965;66:115\u201321.","journal-title":"J Lab Clin Med"},{"key":"1439_CR65","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/jimd.12444","volume":"45","author":"Y Wada","year":"2021","unstructured":"Wada Y, Arai-Ichinoi N, Kikuchi A, Kure S. \u03b2-Galactosidase therapy can mitigate blood galactose elevation after an oral lactose load in galactose mutarotase deficiency. J Inherit Metab Dis. 2021;45:334\u20139.","journal-title":"J Inherit Metab Dis"},{"key":"1439_CR66","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10545-016-9990-5","volume":"40","author":"L Welling","year":"2016","unstructured":"Welling L, Bernstein LE, Berry GT, Burlina AB, Eyskens F, Gautschi M, et al. International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up. J Inherit Metab Dis. 2016;40:171\u20136.","journal-title":"J Inherit Metab Dis"},{"key":"1439_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/gim.2017.172","volume":"20","author":"M Pasquali","year":"2018","unstructured":"Pasquali M, Yu C, Coffee B. Laboratory diagnosis of galactosemia: a technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018;20:3\u201311.","journal-title":"Genet Med"},{"key":"1439_CR68","first-page":"786","volume":"4","author":"JH Kinoshita","year":"1965","unstructured":"Kinoshita JH. Cataracts in galactosemia. The Jonas S. Friedenwald Memorial Lecture. Invest Ophthalmol. 1965;4:786\u201399.","journal-title":"Invest Ophthalmol"},{"key":"1439_CR69","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/hmg\/9.12.1821","volume":"9","author":"Y Ai","year":"2000","unstructured":"Ai Y, Zheng Z, O\u2019Brien-Jenkins A, Bernard DJ, Wynshaw-Boris T, Ning C, et al. A mouse model of galactose-induced cataracts. Hum Mol Genet. 2000;9:1821\u20137.","journal-title":"Hum Mol Genet"},{"key":"1439_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1355962","volume":"15","author":"B Panis","year":"2024","unstructured":"Panis B, Vos EN, Bari\u0107 I, Bosch AM, Brouwers MCGJ, Burlina A, et al. Brain function in classic galactosemia, a galactosemia network (GalNet) members review. Front Genet. 2024;15:1355962.","journal-title":"Front Genet"},{"key":"1439_CR71","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/mp.2011.1","volume":"16","author":"X Liu","year":"2011","unstructured":"Liu X, Cannon DM, Akula N, Moya PR, Knudsen GM, Arentzen TE, et al. A non-synonymous polymorphism in galactose mutarotase (GALM) is associated with serotonin transporter binding potential in the human thalamus: Results of a genome-wide association study. Mol Psychiatry. 2011;16:584\u20135.","journal-title":"Mol Psychiatry"},{"key":"1439_CR72","doi-asserted-by":"crossref","unstructured":"Tian N, Li J, Shi X, Xu M, Xiao Q, Tian Q et al. GALM alleviates A\u03b2 pathology and cognitive deficit through increasing ADAM10 maturation in a mouse model of Alzheimer\u2019s disease. Neurosci Bull. 2025;41:1377\u201389.","DOI":"10.1007\/s12264-025-01386-4"},{"key":"1439_CR73","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1086\/319512","volume":"68","author":"Y Okano","year":"2001","unstructured":"Okano Y, Asada M, Fujimoto A, Ohtake A, Murayama K, Hsiao K-J, et al. A geenetic factor for age-related cataract: Identification and characterization of a novel galactokinase variant, \u201cOsaka,\u201d in Asians. Am J Hum Genet. 2001;68:1036\u201342.","journal-title":"Am J Hum Genet"},{"key":"1439_CR74","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.je.2016.12.005","volume":"27","author":"A Nagai","year":"2017","unstructured":"Nagai A, Hirata M, Kamatani Y, Muto K, Matsuda K, Kiyohara Y, et al. Overview of the BioBank Japan Project: Study design and profile. J Epidemiol. 2017;27:S2\u2013S8.","journal-title":"J Epidemiol"},{"key":"1439_CR75","doi-asserted-by":"crossref","unstructured":"Pomerantz DJ, Demirbas D, Berry GT. Metabolic disorders. In: Rosenberg RN, Pascual JM, editors. Rosenberg\u2019s molecular and genetic basis of neurological and psychiatric disease, 7th edn. Amsterdam: p. 745\u2013759 (Elsevier Academic Press, 2025.","DOI":"10.1016\/B978-0-443-19041-4.00078-9"},{"key":"1439_CR76","unstructured":"Fridovich-Keil JL, Gambello MJ, Singh RH, Sharer JD. Duarte variant galactosemia. In: GeneReviews. Seattle: (University of Washington, 2020)."},{"key":"1439_CR77","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jdiacomp.2013.11.002","volume":"28","author":"D Petrovi\u010d","year":"2014","unstructured":"Petrovi\u010d D. Aldose reductase, glucose and cataracts. J Diab Complicat. 2014;28:120\u20131.","journal-title":"J Diab Complicat"},{"key":"1439_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23873-8","volume":"12","author":"H Choquet","year":"2021","unstructured":"Choquet H, Melles RB, Anand D, Yin J, Cuellar-Partida G, Wang W, et al. A large multiethnic GWAS meta-analysis of cataract identifies new risk loci and sex-specific effects. Nat Commun. 2021;12:3595.","journal-title":"Nat Commun"},{"key":"1439_CR79","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/ije\/dyab175","volume":"50","author":"H Zhang","year":"2021","unstructured":"Zhang H, Xiu X, Xue A, Yang Y, Yang Y, Zhao H. Mendelian randomization study reveals a population-specific putative causal effect of type 2 diabetes in risk of cataract. Int J Epidemiol. 2021;50:2024\u201337.","journal-title":"Int J Epidemiol"},{"key":"1439_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108662","volume":"209","author":"A Shiels","year":"2021","unstructured":"Shiels A, Hejtmancik JF. Inherited cataracts: Genetic mechanisms and pathways new and old. Exp Eye Res. 2021;209:108662.","journal-title":"Exp Eye Res"},{"key":"1439_CR81","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10545-016-9989-y","volume":"40","author":"ME Rubio-Gozalbo","year":"2017","unstructured":"Rubio-Gozalbo ME, Bosch AM, Burlina A, Berry GT, Treacy EP, Steering Committee on behalf of all Galactosemia Network representatives. The galactosemia network (GalNet). J Inherit Metab Dis. 2017;40:169\u201370.","journal-title":"J Inherit Metab Dis"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01439-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01439-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01439-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:02:05Z","timestamp":1765782125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01439-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":81,"alternative-id":["1439"],"URL":"https:\/\/doi.org\/10.1038\/s10038-025-01439-6","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"type":"print","value":"1434-5161"},{"type":"electronic","value":"1435-232X"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Ethics Committee of the Faculty of Medicine at Tohoku University (Miyagi, Japan) approved the study investigating the relationship between cataract occurrence and genetic background (approval number: 2019-1-012). During the preparation of this study, YW utilized ChatGPT5 to enhance readability and language clarity. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}